Cargando…

Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study

BACKGROUND/OBJECTIVE: Treatment of subjects with non-alcoholic fatty liver disease (NAFLD) with omega-3 polyunsaturated fatty acids (FAs) suggests high levels of docosahexaenoic acid (DHA) tissue enrichment decrease liver fat content. We assessed whether changes in erythrocyte DHA enrichment (as a s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hodson, L, Bhatia, L, Scorletti, E, Smith, D E, Jackson, N C, Shojaee-Moradie, F, Umpleby, M, Calder, P C, Byrne, C D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474320/ https://www.ncbi.nlm.nih.gov/pubmed/28294174 http://dx.doi.org/10.1038/ejcn.2017.9

Ejemplares similares

Erratum: Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study
por: Hodson, L, et al.
Publicado: (2017)

The fat mass and obesity-associated (FTO) gene allele rs9939609 and glucose tolerance, hepatic and total insulin sensitivity, in adults with obesity
por: de Soysa, Ann Kristin Hjelle, et al.
Publicado: (2021)

Insulin Detemir Reduces Weight Gain as a Result of Reduced Food Intake in Patients With Type 1 Diabetes
por: Zachariah, Sunil, et al.
Publicado: (2011)

Measurement of hepatic insulin sensitivity early after the bypass of the proximal small bowel in humans
por: Miras, A. D., et al.
Publicado: (2016)

Dysregulated Neurovascular Control Underlies Declining Microvascular Functionality in People With Non-alcoholic Fatty Liver Disease (NAFLD) at Risk of Liver Fibrosis
por: Clough, Geraldine F., et al.
Publicado: (2020)

Growth differentiation factor-15 and the association between type 2 diabetes and liver fibrosis in NAFLD
por: Bilson, Josh, et al.
Publicado: (2021)

Prandial Hypertriglyceridemia in Metabolic Syndrome Is Due to an Overproduction of Both Chylomicron and VLDL Triacylglycerol
por: Shojaee-Moradie, Fariba, et al.
Publicado: (2013)

Exploring the determinants of ethnic differences in insulin clearance between men of Black African and White European ethnicity
por: Ladwa, Meera, et al.
Publicado: (2021)

Lixisenatide Reduces Chylomicron Triacylglycerol by Increased Clearance
por: Whyte, Martin B, et al.
Publicado: (2018)

The Effect of Fructose Feeding on Intestinal Triacylglycerol Production and De Novo Fatty Acid Synthesis in Humans
por: Steenson, Simon, et al.
Publicado: (2020)

Do endocannabinoids acting via hepatic CB-1 contribute to NAFLD and hepatic insulin resistance?
por: Kunos, George, et al.
Publicado: (2022)

Ethnic differences in beta cell function occur independently of insulin sensitivity and pancreatic fat in black and white men
por: Ladwa, Meera, et al.
Publicado: (2021)

Impact of liver fat on the differential partitioning of hepatic triacylglycerol into VLDL subclasses on high and low sugar diets
por: Umpleby, A. Margot, et al.
Publicado: (2017)

Early Life Exposure to Maternal Insulin Resistance Has Persistent Effects on Hepatic NAFLD in Juvenile Nonhuman Primates
por: Thorn, Stephanie R., et al.
Publicado: (2014)

Distinct Hepatic Gene‐Expression Patterns of NAFLD in Patients With Obesity
por: Subudhi, Sonu, et al.
Publicado: (2021)

Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD
por: Fourman, Lindsay T., et al.
Publicado: (2020)

Black African men with early type 2 diabetes have similar muscle, liver and adipose tissue insulin sensitivity to white European men despite lower visceral fat
por: Bello, Oluwatoyosi, et al.
Publicado: (2019)

Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD
por: Takahashi, Hirokazu, et al.
Publicado: (2021)

Hepatic PEMT Expression Decreases with Increasing NAFLD Severity
por: Piras, Ignazio S., et al.
Publicado: (2022)

Diet rich in Docosahexaenoic Acid/Eicosapentaenoic Acid robustly ameliorates hepatic steatosis and insulin resistance in seipin deficient lipodystrophy mice
por: Xu, Pengfei, et al.
Publicado: (2015)

Berberis aristata, Elaeis guineensis and Coffea canephora Extracts Modulate the Insulin Receptor Expression and Improve Hepatic Steatosis in NAFLD Patients: A Pilot Clinical Trial
por: Cossiga, Valentina, et al.
Publicado: (2019)

Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis
por: Bernhardt, Philipp, et al.
Publicado: (2018)

Dietary Docosahexaenoic Acid and Eicosapentaenoic Acid Influence Liver Triacylglycerol and Insulin Resistance in Rats Fed a High-Fructose Diet
por: Salim de Castro, Gabriela, et al.
Publicado: (2015)

The Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Cardiometabolic Risk Factors: A Systematic Review
por: Innes, Jacqueline K., et al.
Publicado: (2018)

Hepatic Steatosis, Carbohydrate Intake, and Food Quotient in Patients with NAFLD
por: Gonzalez, Concepcion, et al.
Publicado: (2013)

Parenteral Nutrition Associated Hepatic Steatosis and NAFLD Intersect at AMPK
por: Guthrie, Gregory
Publicado: (2022)

Reply to: “Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD”
por: van Kleef, Laurens A., et al.
Publicado: (2022)

Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model
por: Niu, Shu, et al.
Publicado: (2022)

Leucine-enriched essential amino acid supplementation in mechanically ventilated trauma patients: a feasibility study
por: Wandrag, L., et al.
Publicado: (2019)

Influence of NAFLD and bariatric surgery on hepatic and adipose tissue mitochondrial biogenesis and respiration
por: Pedersen, Julie S., et al.
Publicado: (2022)

Hepatic FDG uptake in patients with NAFLD: An important prognostic factor for cardio-cerebrovascular events?
por: Dimitriu-Leen, Aukelien C., et al.
Publicado: (2016)

Circulating Docosahexaenoic Acid Levels Are Associated with Fetal Insulin Sensitivity
por: Zhao, Jin-Ping, et al.
Publicado: (2014)

Atorvastatin and Flaxseed Effects on Biochemical Indices and Hepatic Fat of NAFLD Model in Rats
por: Eslami, Zahra, et al.
Publicado: (2023)

Long noncoding RNA licensing of obesity-linked hepatic lipogenesis and NAFLD pathogenesis
por: Zhao, Xu-Yun, et al.
Publicado: (2018)

A comparative analysis of the response of the hepatic transcriptome to dietary docosahexaenoic acid in Atlantic salmon (Salmo salar) post-smolts
por: Glencross, Brett D., et al.
Publicado: (2015)

Knowledge-Based Identification of Soluble Biomarkers: Hepatic Fibrosis in NAFLD as an Example
por: Page, Sandra, et al.
Publicado: (2013)

NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations
por: Adinolfi, Luigi Elio, et al.
Publicado: (2016)

Roles of hepatic stellate cells in NAFLD: From the perspective of inflammation and fibrosis
por: Wang, Man, et al.
Publicado: (2022)

A Computational Model of Hepatic Energy Metabolism: Understanding Zonated Damage and Steatosis in NAFLD
por: Ashworth, William B., et al.
Publicado: (2016)

How dietary arachidonic- and docosahexaenoic- acid rich oils differentially affect the murine hepatic transcriptome
por: Berger, Alvin, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_cuvjovpldaaqqd25miq06kff9d